background
nosocomi
infect
healthcar
worker
hcw
outbreak
respiratori
infect
eg
influenza
signific
concern
public
health
polici
maker
world
health
organ
defin
aerosol
gener
procedur
agp
thought
increas
risk
aerosol
transmiss
hcw
present
insuffici
data
quantifi
risk
accur
establish
hierarchi
riskpron
procedur
methodologyprincip
find
studi
measur
amount
rna
aerosol
vicin
posit
patient
undergo
agp
help
quantifi
potenti
risk
transmiss
hcw
sampl
occas
window
produc
total
may
stage
analysi
size
rang
mm
consid
stage
mm
mm
compris
one
sampl
viral
rna
detect
air
sampl
patient
twenti
three
air
sampl
collect
potenti
agp
perform
contain
viral
rna
contrast
may
sampl
collect
defin
agp
perform
contain
viral
rna
unadjust
ci
adjust
conclusionssignific
small
sampl
size
found
agp
significantli
increas
probabl
sampl
posit
aerosol
ci
although
probabl
detect
posit
posit
aerosol
perform
variou
agp
intens
care
patient
baselin
rate
ie
absenc
agp
reach
signific
trend
toward
hierarchi
agp
place
bronchoscopi
respiratori
airway
suction
baselin
background
valu
larger
studi
requir
preliminari
find
may
benefit
infect
control
team
least
healthcar
worker
hcw
infect
sarscoronaviru
sever
acut
respiratori
syndrom
epidem
nosocomi
infect
primari
acceler
infect
account
case
toronto
probabl
case
taiwan
aerosol
gener
procedur
agp
perform
infect
patient
implic
sourc
outbreak
among
health
care
worker
hcw
howev
direct
evid
mode
transmiss
demonstr
sever
medic
procedur
report
gener
aerosol
increas
risk
pathogen
transmiss
respons
concern
world
health
organ
produc
guidelin
infect
control
procedur
person
protect
equip
refin
tabl
guidelin
incorpor
avail
data
relat
infect
potenti
agp
mani
studi
contain
methodolog
flaw
preclud
use
conclus
draw
recommend
accept
level
understand
aerobiolog
agp
may
evolv
particular
risk
associ
individu
agp
quantifi
risk
hierarchi
establish
despit
scientif
limit
guidelin
use
plan
infect
control
subsequ
pandem
addit
controversi
remain
import
aerosol
transmiss
influenza
absenc
agp
ongo
uncertainti
reflect
divers
approach
adopt
differ
countri
relat
recommend
use
surgic
face
mask
sfm
respir
hcw
pandem
guidanc
state
standard
droplet
precaut
ie
sfm
adopt
work
direct
contact
infect
patient
high
level
respiratori
protect
equip
minimum
class
respir
worn
vicin
infect
patient
agp
perform
result
infect
control
strategi
adopt
uk
nh
organis
infecti
pathogen
may
contain
aerosol
gener
recognis
mm
aerodynam
diamet
remain
suspend
period
time
travel
signific
distanc
safeti
presenc
infecti
aerosol
requir
respiratori
protect
equip
uk
standard
respir
protect
expos
hcw
human
influenza
infect
viru
emiss
occur
via
cough
sneez
produc
respiratori
spray
contain
particl
size
continuum
mm
initi
outbreak
subsequ
worldwid
spread
influenza
provid
opportun
perform
air
sampl
defin
viral
rna
copi
number
size
aerosol
agp
defin
produc
rel
burden
compar
freeli
respir
patient
primari
object
studi
establish
world
health
organ
defin
aerosol
gener
procedur
produc
infecti
aerosol
detect
cloud
produc
determin
infecti
aerosol
concentr
particl
size
use
inform
inform
infect
control
practic
air
sampl
around
hospitalis
patient
suspect
proven
lower
respiratori
tract
infect
locat
either
pandem
isol
room
singl
occup
room
cohort
area
ward
numer
patient
suspect
confirm
posit
place
away
patient
sampl
perform
differ
hospit
locat
around
england
uk
studi
perform
octob
januari
peak
sampl
time
correspond
known
period
heighten
activ
potenti
recruit
identifi
particip
unit
local
princip
investig
inform
sampl
team
sampl
team
deploy
unit
highest
level
overal
activ
patient
inclus
criteria
defin
new
chest
xray
chang
eg
consolid
alveolar
infiltr
atelectasi
presenc
one
follow
central
temperatur
children
white
blood
cell
count
cellsmm
cellsmm
posit
microbiolog
virolog
respiratori
secret
mucopurul
secret
respiratori
tract
figur
air
sampl
investig
record
clinic
intervent
perform
well
temperatur
rel
humid
time
locat
air
sampl
activ
level
patient
sex
age
diagnost
specimen
type
result
time
sinc
admiss
use
data
two
consult
physician
jp
mb
blind
air
sampl
data
statu
patient
independ
code
intervent
agp
met
definit
tabl
disagr
discuss
consensu
reach
baselin
sampl
taken
intervent
meet
definit
agp
taken
least
minut
defin
agp
complet
recruit
least
one
baselin
sampl
event
incid
defin
agp
rarer
investig
attempt
captur
mani
possibl
glass
may
imping
produc
hpa
porton
oper
litr
per
minut
place
meter
height
within
meter
patient
head
use
collect
air
sampl
maximum
minut
baselin
sampl
taken
minut
air
collect
ml
steril
nucleas
free
molecular
grade
phosphat
buffer
salin
may
imping
fraction
air
particl
aerodynam
size
rang
stage
collect
particl
mm
stage
collect
particl
rang
mm
stage
collect
particl
mm
liquid
air
sampl
transport
laboratori
frozen
dri
ice
store
analysi
sampl
team
staffvisitor
wear
respir
cohort
area
isol
room
pandem
addit
sampl
team
proport
staffvisitor
vaccin
pandem
strain
major
patient
intens
care
unit
close
ventil
circuit
mean
unlik
influenza
aerosol
could
gener
anyon
patient
agp
perform
case
baselin
sampl
often
form
nonagp
classifi
activ
ongo
eg
activ
associ
chest
physiotherapi
respiratori
care
sampl
repres
control
sampl
activ
take
place
mere
repres
air
sampl
taken
activ
could
defin
agp
take
place
arriv
laboratori
sampl
store
prior
rna
extract
sampl
concentr
ml
use
kd
macrosep
centrifug
devic
g
hour
viral
rna
present
within
result
concentr
extract
use
qiagen
qiaamp
viral
rna
spin
protocol
qiagen
uk
elut
ml
volum
elut
buffer
subsequ
pool
sampl
frozen
defrost
prior
use
qrtpcr
assay
paninfluenza
qrtpcr
assay
base
paninfluenza
segment
assay
develop
spackman
et
al
use
detect
presenc
influenza
rna
within
sampl
primer
probe
concentr
rna
templat
volum
reoptimis
condit
origin
describ
hydrolysi
probe
also
adapt
use
black
hole
quencher
bhq
rather
carboxytetramethylrhodamin
tamra
increas
assay
sensit
standard
curv
also
ad
assay
allow
quantif
influenza
rna
within
sampl
prepar
use
pandem
influenza
viru
rna
extract
live
viru
prepar
perform
use
qiaamp
viral
rna
mini
kit
qiagen
fulllength
influenza
segment
amplifi
rtpcr
use
rt
primer
pcr
primer
r
describ
hoffman
et
al
amplicon
purifi
wv
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
clone
pcr
topo
vector
heatshock
e
coli
cell
describ
topo
ta
clone
kit
invitrogen
construct
pcr
topocalm
influenza
segment
insert
within
pcr
topocalm
confirm
sequenc
use
forward
revers
prime
site
flank
insert
data
shown
segment
sequenc
amplifi
topocalm
pcr
use
primer
contain
rna
polymeras
promot
sequenc
highlight
ital
neg
sens
rna
transcript
segment
sequenc
gener
pcr
amplicon
amplicon
subsequ
remov
dnase
digest
use
megascript
kit
ambion
dnase
digest
amplicon
templat
confirm
agaros
get
electrophoresi
rna
transcript
purifi
use
rneasi
mini
kit
qiagen
rna
cleanup
protocol
copi
number
calcul
follow
determin
rna
transcript
concentr
nanodrop
spectrophotmet
qrtpcr
reaction
perform
plate
use
superscript
iii
platinum
onestep
quantit
rtpcr
kit
invitrogen
run
appli
biosystem
realtim
pcr
system
plate
consist
standard
curv
prepar
tenfold
dilut
seri
segment
rna
transcript
h
also
act
assay
posit
control
nontempl
neg
control
molecular
grade
water
rna
process
air
sampl
control
sampl
run
duplic
qrtpcr
reaction
consist
ml
ml
oligo
aga
tga
gtc
ttc
taa
ccg
agg
tcg
nm
final
concentr
ml
oligo
tgc
aaa
aac
atc
ttc
aag
tct
ctg
nm
final
concentr
ml
rox
ml
taqsuperscript
enyzm
ml
probe
famtca
ggc
ccc
ctc
aaa
gcc
gabhq
nm
final
concentr
ml
either
sampl
rna
standard
curv
rna
neg
control
dh
reach
final
volum
ml
influenza
qrtpcr
cycl
condit
minut
minut
follow
cycl
second
second
number
viru
copieslitr
sampl
determin
use
standard
curv
r
valu
typic
studi
approv
oxfordshir
local
research
ethic
committe
rec
refer
requir
inform
consent
waiv
committe
agre
studi
constitut
intrus
research
involv
process
nonidentifi
data
committe
felt
provis
mental
capac
act
appli
studi
committe
welcom
statement
research
would
alway
seek
view
patient
parent
andor
rel
prior
start
take
air
sampl
would
respond
concern
sampl
start
committe
constitut
accord
govern
arrang
research
ethic
committe
juli
compli
fulli
standard
oper
procedur
research
ethic
committe
uk
statist
analysi
perform
stata
softwar
version
stata
corp
colleg
station
tx
usa
patient
confirm
influenza
rtpcr
posit
respiratori
tract
sampl
consid
statist
analysi
univari
logist
regress
model
use
examin
relationship
propens
produc
posit
aerosol
sampl
number
potenti
risk
factor
wald
test
use
assess
risk
factor
signific
sampl
consid
posit
aerosolis
influenza
particl
either
may
stage
mm
indic
presenc
copi
number
stage
sum
give
total
copi
number
sampl
occas
random
effect
includ
logist
model
subject
level
account
potenti
correl
caus
repeat
measur
individu
instanc
posit
sampl
produc
univari
neg
binomi
regress
model
correct
sampl
durat
use
examin
relationship
total
copi
number
per
litr
per
minut
potenti
risk
factor
three
particip
gave
one
posit
sampl
random
subjectlevel
effect
use
neg
binomi
regress
instead
robust
standard
error
use
adjust
potenti
correl
model
final
probabl
obtain
posit
sampl
viral
load
obtain
posit
sampl
model
rank
procedur
list
chest
physiotherapi
produc
hierarchi
procedur
basi
potenti
risk
classic
definit
risk
equal
probabl
time
consequ
use
henc
multipli
predict
logist
neg
binomi
model
togeth
order
obtain
risk
measur
give
expect
valu
copi
number
lmin
associ
procedur
total
patient
studi
howev
patient
later
confirm
influenza
rtpcr
posit
includ
statist
analysi
tabl
show
percentag
total
rna
found
stage
may
imping
tabl
rna
collect
stage
procedur
tabl
tabl
show
rna
recov
baselin
sampl
recov
mm
size
rang
total
rna
total
rna
recov
baselin
sampl
contrast
total
amount
rna
recov
bronchoscopi
sampl
confound
limit
sampl
size
collect
stage
mm
situat
similar
respiratori
airway
suction
total
rna
mm
size
rang
therefor
result
indic
agp
defin
definit
tend
produc
aerosol
smaller
particl
size
baselin
level
figur
show
patient
inclus
process
paper
interest
abil
agp
gener
aerosol
rather
respiratori
droplet
subsequ
analysi
deal
result
second
third
stage
particl
size
mm
may
sampler
howev
full
result
seen
onlin
supplement
tabl
show
patient
demograph
togeth
characterist
sampl
sampl
occas
window
produc
total
may
stage
analysi
size
rang
mm
tabl
fortysix
air
stage
sampl
collect
potenti
agp
accord
definit
see
tabl
perform
contain
viral
rna
contrast
may
stage
sampl
collect
defin
agp
perform
contain
viral
rna
unadjust
ci
adjust
may
stage
analysi
mm
size
rang
air
stage
sampl
collect
potenti
agp
perform
contain
viral
rna
may
stage
sampl
collect
agp
perform
contain
viral
rna
statist
signific
unadjust
result
logist
regress
tabl
indic
adjust
repeat
measur
none
variabl
examin
signific
influenc
product
posit
aerosol
tabl
valu
estim
odd
ratio
likelihood
produc
pcr
posit
air
sampl
particl
size
rang
mm
presenc
agp
categor
variabl
agp
signific
subjectlevel
random
effect
obtain
null
logist
model
indic
one
individu
studi
significantli
higher
propens
averag
produc
posit
sampl
other
rais
propens
coupl
lack
signific
relationship
given
tabl
suggest
propens
produc
posit
sampl
relat
unmeasur
individuallevel
attribut
demograph
measur
characterist
variat
caus
unmeasur
attribut
high
subjectlevel
random
effect
wide
confid
interv
varianc
partit
coeffici
vpc
null
logist
model
indic
total
varianc
propens
produc
posit
sampl
due
differ
individu
exampl
age
hospit
locat
henc
due
differ
within
individu
exampl
stage
infect
unfortun
enough
data
analys
individu
time
investig
result
neg
binomi
regress
also
given
tabl
copi
number
per
litr
significantli
posit
associ
case
age
year
incid
rate
ratio
irr
compar
refer
ci
case
hospit
locat
irr
significantli
neg
associ
day
sinc
diagnosi
irr
day
sinc
last
posit
sampl
irr
rel
humid
irr
howev
agp
categoris
found
associ
copi
number
suggest
agp
associ
high
copi
number
other
associ
low
copi
number
reveal
irr
estim
variou
agp
categori
rang
tabl
howev
inconclus
low
number
categori
analysi
influenc
viru
quantiti
aerosol
like
subject
confound
low
number
posit
sampl
possibl
correl
risk
factor
data
analys
regard
agp
definit
broad
agreement
result
detail
tabl
also
includ
procedur
relat
chest
physiotherapi
analysi
agp
agp
tabl
result
suggest
chest
physiotherapi
associ
increas
probabl
aerosol
product
includ
agp
model
aerosol
titr
lower
baselin
sampl
irr
establish
relationship
differ
agp
data
model
determin
hierarchi
procedur
term
potenti
risk
gener
infecti
aerosol
tabl
found
whilst
agp
associ
higher
probabl
sampl
posit
aerosol
also
except
bronchoscopi
associ
lower
copi
number
lmin
background
sampl
lessen
overal
risk
tabl
bronchoscopi
respiratoryairway
suction
found
risk
greater
encount
baselin
background
sampl
evid
regard
role
agp
transmiss
influenza
hospit
set
limit
result
tabl
indic
smaller
particl
preferenti
produc
agp
procedur
compar
baselin
sampl
howev
total
level
rna
recov
higher
baselin
sampl
ie
larg
particl
contain
higher
quantiti
rna
vs
smaller
particl
contain
smaller
quantiti
rna
due
limit
sampl
method
imposs
quantifi
total
number
particl
particl
size
indic
quantiti
rna
collect
particl
size
rang
one
might
specul
other
done
dispers
aerosol
low
concentr
influenza
contain
small
particl
might
potenti
transmiss
morbid
risk
larg
particl
contain
significantli
total
influenza
studi
detect
influenza
viru
rna
airsampl
window
particl
mm
patient
broad
agreement
report
differ
health
care
set
particular
note
fact
data
analys
propens
airsampl
event
produc
posit
air
sampl
mm
aerodynam
size
rang
none
variabl
investig
studi
significantli
increas
probabl
obtain
posit
air
sampl
either
analysi
howev
variabl
potenti
air
sampler
detect
posit
air
sampl
due
number
factor
includ
room
ventil
pattern
air
particl
initi
veloc
temperatur
rel
humid
distanc
sourc
even
signific
level
uncertainti
low
sampl
number
estim
adjust
agp
vs
non
agp
set
p
taken
togeth
unadjust
context
small
studi
size
find
suggest
true
effect
ie
agp
current
defin
definit
increas
likelihood
gener
infecti
aerosol
extent
may
relev
clinic
set
howev
almost
certainli
encount
type
ii
statist
error
due
small
number
data
therefor
requir
analysi
specif
procedur
show
bronchoscopi
associ
greatest
probabl
aerosol
product
intub
relat
procedur
respiratoryairway
suction
chest
physiotherapi
also
show
increas
probabl
although
none
result
attain
statist
signific
quantiti
viral
rna
known
vari
patient
within
individu
patient
timecours
ill
patient
earli
cours
infect
excret
higher
titr
viru
thu
might
gener
aerosol
contain
viral
rna
studi
total
varianc
propens
produc
posit
sampl
due
differ
individu
due
differ
within
individu
unfortun
ethic
committe
approv
obtain
respiratori
tract
specimen
patient
thu
although
determin
diagnost
statu
specimen
taken
attend
physician
basi
recruit
studi
correl
air
sampl
find
patient
viru
concentr
mani
studi
also
note
high
variabl
number
viru
particl
expel
subject
infect
respiratori
pathogen
therefor
work
consist
previou
studi
influenza
rna
load
posit
air
sampl
like
influenc
sourc
aerosol
ie
patient
locat
within
patient
aerosol
produc
recent
paper
johnson
et
al
suggest
aerosol
differ
particl
size
produc
differ
area
respiratori
tract
differ
activ
perform
cough
breath
talk
although
investig
studi
result
suggest
aerosol
detect
studi
could
origin
differ
part
respiratori
tract
could
account
wide
rang
viral
titr
pick
viral
load
differ
along
respiratori
tract
individu
differ
procedur
differ
abil
produc
aerosol
wide
rang
viral
titr
would
expect
howev
also
true
variabl
data
caus
differ
imping
proxim
orient
direct
air
flow
human
activ
produc
turbul
air
condit
ventil
level
sampl
site
result
indic
although
small
sampl
size
prohibit
firm
conclus
perform
bronchoscopi
increas
viral
copi
number
per
litr
posit
air
sampl
factor
ci
intub
relat
procedur
respiratoryairway
suction
show
decreas
irr
respect
first
evid
suggest
agp
eg
bronchoscopi
may
confer
greater
risk
transmiss
hcw
other
order
understand
risk
hierarchi
titr
probabl
posit
sampl
use
construct
risk
summari
stratif
tabl
tabl
tabl
tabl
demograph
patient
specif
condit
air
sampl
copi
number
influenza
viru
recov
posit
air
sampl
strongli
influenc
hospit
locat
age
rang
day
sinc
diagnosi
day
sinc
last
posit
diagnost
sampl
air
sampl
volum
rel
humid
p
hospit
locat
number
significantli
higher
viral
concentr
recov
posit
air
sampl
potenti
hospit
tertiari
referr
centr
respiratori
ill
provid
extracorpor
membran
oxygen
ecmo
adult
outbreak
addit
bronchoscopi
perform
locat
hospit
contain
patient
higher
averag
propens
produc
posit
sampl
age
shown
signific
effect
patient
age
year
highest
rate
aerosol
gener
contrast
would
expect
previou
studi
appar
agerel
effect
could
due
outli
result
patient
significantli
higher
propens
averag
produc
posit
air
sampl
group
neg
associ
copi
number
recov
number
day
diagnosi
sampl
found
would
expect
signific
relationship
high
rel
humid
lower
recoveri
viral
rna
correl
previou
studi
studi
sever
limit
firstli
perform
biolog
assay
quantifi
viabil
infecti
potenti
viral
materi
although
influenza
viru
capabl
surviv
air
indoor
environ
data
regard
stabil
pandem
aerosol
success
cultur
viabl
virus
environment
sampl
technic
difficult
thu
rel
insensit
bioassay
infect
howev
believ
detect
viru
rna
aerosol
within
second
gener
favour
deriv
viabl
virus
secondli
even
aerosol
appropri
concentr
reach
health
care
worker
inhal
inhal
necessarili
equat
infect
infect
depend
upon
infecti
dose
rout
inhal
nose
mouth
tidal
volum
breath
rate
time
underli
suscept
immun
statu
also
depend
upon
particl
size
particl
enter
distal
lung
need
mm
deposit
sampl
wide
rang
differ
hospit
difficult
establish
get
inform
ventil
rate
pattern
hospit
within
differ
area
hospit
gener
isol
room
higher
ventil
rate
ward
cohort
area
cohort
area
open
window
form
ventil
evid
obvious
imposs
investig
fulli
area
sampl
due
time
logist
constraint
busi
environ
studi
therefor
give
indic
level
influenza
rna
healthcar
worker
could
expos
thirdli
estim
aerosol
infecti
dose
previou
studi
difficult
due
lack
studi
area
health
ethic
reason
howev
alford
et
al
found
aerosol
infecti
dose
influenza
tcid
equat
roughli
viru
particl
accord
teuni
et
al
potenti
exposur
hcw
agp
roughli
calcul
use
aerosol
concentr
breath
rate
exposur
time
assum
femal
hcw
breath
rate
lmin
agp
last
minut
litr
air
inhal
procedur
model
concentr
viral
copi
number
found
bronchoscopi
posit
air
sampl
copieslitreminut
suggest
expect
exposur
would
viru
copi
exposur
significantli
greater
tcid
aerosol
infecti
dose
report
alford
et
al
studi
also
show
signific
exposur
aerosol
model
copi
number
copi
litreminut
occur
absenc
recogn
agp
vicin
studi
killingley
et
al
suggest
exposur
aerosol
influenza
may
regularli
occur
epidem
icu
hospit
mani
environ
fourthli
may
imping
collect
particl
mm
aerodynam
particl
size
sever
studi
report
find
influenza
rna
air
particl
mm
thu
possibl
aerosol
rna
miss
final
larg
complex
studi
involv
collabor
laboratori
sampl
team
busi
clinician
five
hospit
due
limit
resourc
lack
time
ethic
constraint
full
clinic
inform
patient
avail
like
patient
repres
full
spectrum
clinic
present
patient
would
earli
cours
infect
other
infect
week
therefor
inform
viral
load
immedi
prior
air
sampl
avail
addit
numer
technic
difficulti
associ
recoveri
influenza
air
potenti
mani
addit
posit
air
sampl
miss
due
reason
previous
discuss
notwithstand
constraint
impos
small
number
data
indic
agp
defin
appear
relat
increas
likelihood
viral
aerosol
gener
data
particularli
clear
bronchoscopi
respiratoryairway
suction
conclud
agp
potenti
pose
threat
infect
transmiss
health
care
worker
data
avail
uk
infect
control
polici
use
highfiltr
face
piec
respect
respir
perform
agp
remain
appropri
continu
practic
accord
local
guidelin
data
avail
